Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Maya Martinez-Davis. Insider active across 1 company, notably GSK plc. Aggregated, 32 reports have been recorded. History available since 9 February 2026. The latest transaction was disclosed on 20 August 2026 (Sale). Regulator: RNS (LSE). All data is accessible without signup.
Companies and markets linked to Maya Martinez-Davis Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 32 total
● President, US · Executives · 20 Aug 2026 · GSK plc 3,916 shares @ £0.5215 ISIN ISIN US37733W2044FCA-NSM:960dc079-2d29-45dc-ae26-4620c41ddfc4-0 ● President, US · Executives · 21 Aug 2026 · GSK plc 40,481 shares @ £0.5216 ISIN ISIN US37733W2044FCA-NSM:960dc079-2d29-45dc-ae26-4620c41ddfc4-1 ● President, US · Executives · 14 Jul 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:9673287-1 ● President, US · Executives · 10 Jul 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:9673287-3 ● President, US · Executives · 10 Jul 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:68763dee-a518-4ccc-8d25-48330cbfa37e-3 ● President, US · Executives · 14 Jul 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:68763dee-a518-4ccc-8d25-48330cbfa37e-1 ● President, US · Executives · 7 Jul 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:9661747 ● President, US · Executives · 7 Jul 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:289d903e-7ee1-4fa9-bcbd-3a43dc019bc2 ● President, US · Executives · 22 Jun 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:9635096 ● President, US · Executives · 22 Jun 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:f96aec1d-517b-42fe-998e-999eab24c64e ● President, US · Executives · 8 Jun 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:9612073 ● President, US · Executives · 8 Jun 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:c5a93bfc-97ef-49a5-bcc4-05857b3c3b90 ● President, US · Executives · 22 May 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:9588311 ● President, US · Executives · 22 May 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:75c0e8d5-7c01-408c-a26c-84c6611b8f73 ● President, US · Executives · 15 May 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:9576175-2 ● President, US · Executives · 15 May 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:0c2b3473-feab-43c0-81c0-8a4af4e4f91f-2 ● President, US · Executives · 7 May 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:2a6a278d-267e-49ac-b714-020088a48904 ● President, US · Executives · 22 Apr 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:d5dec057-3334-4101-a527-1f9a20145e3c ● President, US · Executives · 14 Apr 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-18 ● President, US · Executives · 14 Apr 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-19 ● President, US · Executives · 7 Apr 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:e48c2f19-f550-4e43-bacf-e5379f6d6b51 ● President, US · Executives · 23 Mar 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:0a1152a8-d690-40e8-bef2-2b869d712c3f ● President, US · Executives · 13 Mar 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:a9ad7e9f-8439-4151-8c1a-69008fbc3c27 ● President, US · Executives · 9 Mar 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:08be650c-10c4-4fa5-9cae-5b89efa04716-9 ● President, US · Executives · 20 Feb 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:5828e747-31e9-4d32-b844-dd5ef59cb57b 25 of 32 declarations
Load more (7 remaining) About Maya Martinez-Davis Maya Martinez-Davis is a declarant linked to GSK plc, where she is President, US. Across 30 filings in total, the 30 sampled filings run from 2026-02-11 to 2026-07-17, with EUR 0 of purchases and EUR 1896 of sales in this recent sample.